Esen, MustafaAkdeniz, NadiyeAn, İsaYüce, Gurbet Acar2024-04-242024-04-2420182564-6567https://doi.org/10.25000/acem.409592https://search.trdizin.gov.tr/yayin/detay/292880https://hdl.handle.net/11468/27925Vandetanib is a multi-kinase inhibitor of epidermal growth factor receptor (EGFR),vascular endothelial growth factor (VEGFR). Most common dermatological side effectsinduced by vandetanib include papulopustular eruption, hand-foot syndrome, andhyperpigmentation.In this report, we present a case with metastatic medullar thyroid carcinoma whodeveloped vandetanib-induced photoallergic dermatitis.eninfo:eu-repo/semantics/openAccessArticle32949629288010.25000/acem.409592